The global healthcare landscape is witnessing significant developments in autoimmune thyroid disease management, with Hashimoto thyroiditis emerging as a critical focus area for pharmaceutical innovation. This chronic autoimmune condition, affecting predominantly women and representing the leading cause of hypothyroidism worldwide, has created considerable market...
English
العربية
Français
Español
Português
Deutsch
Türkçe
Nederlands
Italiano
Русский
Română
Ελληνικά
Tiếng Việt